CVRx Set to Join Russell 2000 & 3000 Indexes
22 juin 2023 16h30 HE
|
CVRx, Inc.
MINNEAPOLIS, June 22, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Present at the William Blair 43rd Annual Growth Stock Conference
25 mai 2023 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, May 25, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx Reports First Quarter 2023 Financial and Operating Results
27 avr. 2023 16h15 HE
|
CVRx, Inc.
MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023
20 avr. 2023 16h30 HE
|
CVRx, Inc.
MINNEAPOLIS, April 20, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure
21 mars 2023 11h02 HE
|
CVRx, Inc.
MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call
16 mars 2023 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative...
CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial
21 févr. 2023 07h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative...
CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
26 janv. 2023 16h15 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023
12 janv. 2023 17h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
09 janv. 2023 08h45 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...